Dawei Zhang
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 3
-
- Cancer, Hypoxia, and Metabolism 4
- Physiology top 10%
-
- interferon and immune responses 2
-
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
-
- Nanoplatforms for cancer theranostics 3
-
- High Altitude and Hypoxia 3
-
- Topic Modeling 2
- Co-authors
- Wuhan XiaoXing LiuGang OuyangJing WangZhaohui TangXiaolian CaiXuesi ChenHaiyang Yu
In The Last Decade
Dawei Zhang
26 papers receiving 701 citations
Peers
Comparison fields: 5 of 104
- Biomaterials 155
- Cancer Research 131
- Physiology 37
- Immunology 119
- Molecular Biology 307
Countries citing papers authored by Dawei Zhang
This map shows the geographic impact of Dawei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Zhang more than expected).
Fields of papers citing papers by Dawei Zhang
This network shows the impact of papers produced by Dawei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Zhang. The network helps show where Dawei Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dawei Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 8 | |
| 4 | 2021 | 3 | |
| 5 | 2021 | 8 | |
| 6 | 2020 | 24 | |
| 7 | 2020 | 64 | |
| 8 | 2020 | 15 | |
| 9 | 2018 | 11 | |
| 10 | 2018 | 34 | |
| 11 | 2018 | 28 | |
| 12 | 2018 | 45 | |
| 13 | 2017 | 23 | |
| 14 | 2017 | 36 | |
| 15 | 2016 | 29 | |
| 16 | 2016 | 2 | |
| 17 | 2015 | 8 | |
| 18 | 2014 | 122 | |
| 19 | 2008 | 6 | |
| 20 | 2004 | 36 |
About Dawei Zhang
Dawei Zhang is a scholar working on Aging, Cancer Research and Biomaterials, having authored 27 papers that have together received 710 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Nanoplatforms for cancer theranostics (3 papers), Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers), High Altitude and Hypoxia (3 papers), interferon and immune responses (2 papers) and Topic Modeling (2 papers). The work is most often cited by research in Biomaterials (155 citations), Cancer Research (131 citations) and Physiology (37 citations). Dawei Zhang has collaborated with scholars based in China, Canada and India. Frequent co-authors include Wuhan Xiao, Xing Liu, Gang Ouyang, Jing Wang, Zhaohui Tang, Xiaolian Cai, Xuesi Chen, Haiyang Yu, Wantong Song and Mingxiao Deng. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.